![Fludarabine, adriamycin and dexamethasone (FAD) in newly diagnosed advanced follicular lymphoma: a phase II study by the British National Lymphoma Investigation (BNLI) | British Journal of Cancer Fludarabine, adriamycin and dexamethasone (FAD) in newly diagnosed advanced follicular lymphoma: a phase II study by the British National Lymphoma Investigation (BNLI) | British Journal of Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fsj.bjc.6602031/MediaObjects/41416_2004_Article_BF6602031_Fig1_HTML.gif)
Fludarabine, adriamycin and dexamethasone (FAD) in newly diagnosed advanced follicular lymphoma: a phase II study by the British National Lymphoma Investigation (BNLI) | British Journal of Cancer
Meta-analysis of overall response rate (ORR), 6-month progression-free... | Download Scientific Diagram
![Overall survival among 360 patients with newly‐diagnosed acute myeloid... | Download Scientific Diagram Overall survival among 360 patients with newly‐diagnosed acute myeloid... | Download Scientific Diagram](https://www.researchgate.net/publication/349031886/figure/fig1/AS:11431281173645644@1689000068957/Overall-survival-among-360-patients-with-newly-diagnosed-acute-myeloid-leukemia-AML-and_Q320.jpg)
Overall survival among 360 patients with newly‐diagnosed acute myeloid... | Download Scientific Diagram
![Weekly nab-Paclitaxel in Combination With Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Analysis of Safety and Efficacy in Patients With Renal Impairment - ScienceDirect Weekly nab-Paclitaxel in Combination With Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Analysis of Safety and Efficacy in Patients With Renal Impairment - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1525730414001910-gr1.jpg)
Weekly nab-Paclitaxel in Combination With Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Analysis of Safety and Efficacy in Patients With Renal Impairment - ScienceDirect
![Overall survival among 360 patients with newly‐diagnosed acute myeloid... | Download Scientific Diagram Overall survival among 360 patients with newly‐diagnosed acute myeloid... | Download Scientific Diagram](https://www.researchgate.net/publication/349031886/figure/fig1/AS:11431281173645644@1689000068957/Overall-survival-among-360-patients-with-newly-diagnosed-acute-myeloid-leukemia-AML-and.png)
Overall survival among 360 patients with newly‐diagnosed acute myeloid... | Download Scientific Diagram
![A) Overall response rate by cohorts. ORR indicates a response of PR or... | Download Scientific Diagram A) Overall response rate by cohorts. ORR indicates a response of PR or... | Download Scientific Diagram](https://www.researchgate.net/publication/348022825/figure/fig1/AS:11431281173673712@1689003069941/A-Overall-response-rate-by-cohorts-ORR-indicates-a-response-of-PR-or-better-ORR.png)
A) Overall response rate by cohorts. ORR indicates a response of PR or... | Download Scientific Diagram
![ICI response of TMB-high vs TMB low groups, for different cancer types. | Download Scientific Diagram ICI response of TMB-high vs TMB low groups, for different cancer types. | Download Scientific Diagram](https://www.researchgate.net/publication/359776929/figure/fig1/AS:1183051740643328@1659072923140/ICI-response-of-TMB-high-vs-TMB-low-groups-for-different-cancer-types.jpg)